| dbo:abstract
|
- Plexxikon est une entreprise américaine spécialisée dans la recherche médicale et basée à Berkeley (Californie). Elle est fondée en 2001 par de l'université Yale et de l'université de Californie à Berkeley. En avril 2011, Plexxikon est achetée par l'entreprise pharmaceutique japonaise Daiichi Sankyo pour 805 millions USD et 130 millions de dollars supplémentaires payés par échelonnement. (fr)
- Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley. It uses a proprietary structural biology-based platform called Scaffold-Based Drug Discovery to build a pipeline of products in multiple therapeutic areas. This discovery process integrates multiple technologies, including structural screening as one key component, that it hopes will give a significant competitive advantage over other approaches. In April 2011, Plexxikon was acquired by the Japanese pharmaceutical company Daiichi Sankyo for $805 million and an additional $130 million in potential milestone payments. Daiichi Sankyo announced the shutdown of Plexxikon in 2022. (en)
|
| dbo:fate
|
- Acquired by theDaiichi Sankyo (en)
|
| dbo:foundedBy
| |
| dbo:foundingYear
| |
| dbo:headquarter
| |
| dbo:industry
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4614 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:fate
|
- Acquired by the Daiichi Sankyo (en)
|
| dbp:founder
| |
| dbp:hqLocation
| |
| dbp:industry
| |
| dbp:name
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Plexxikon est une entreprise américaine spécialisée dans la recherche médicale et basée à Berkeley (Californie). Elle est fondée en 2001 par de l'université Yale et de l'université de Californie à Berkeley. En avril 2011, Plexxikon est achetée par l'entreprise pharmaceutique japonaise Daiichi Sankyo pour 805 millions USD et 130 millions de dollars supplémentaires payés par échelonnement. (fr)
- Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley. It uses a proprietary structural biology-based platform called Scaffold-Based Drug Discovery to build a pipeline of products in multiple therapeutic areas. This discovery process integrates multiple technologies, including structural screening as one key component, that it hopes will give a significant competitive advantage over other approaches. (en)
|
| rdfs:label
|
- Plexxikon (fr)
- Plexxikon (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
